Work

Adjunctive sapropterin dihydrochloride treatment in schizophrenia: A positive proof-of-concept, rater-blind, randomized, multivitamin-controlled study

Year: 2020

Type: article

Source: Schizophrenia Research

DOI: 10.1016/j.schres.2019.12.039

Authors: Catherine L. Clelland, Joshua T. Kantrowitz, Tse Choo, James D. Clelland, Jeffrey A. Lieberman

Institutions: Columbia University Irving Medical Center, Nathan Kline Institute for Psychiatric Research, New York State Psychiatric Institute

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Stanley Medical Research Institute, National Institutes of Health, National Institute of Mental Health, National Center for Advancing Translational Sciences

Awards: Negative Symptoms in Clinical High Risk and First Episode Psychiatric Illness: Investigation of a New Candidate for Targeted Treatment., Clinical and Translational Science Award

OpenAlex ID: W3003107878

FWCI: 0.364

Cites: 12

Cited by: 2

Related to: 10